Recent Finacing
Recent Raise
Akebia Therapeutics is a Cincinnati-based pharmaceutical discovery and development company developing small-molecule therapies for anemia—notably AKB-6548, an oral HIF-PH inhibitor in Phase 2 for CKD/ESRD—and vascular programs including AKB-9778.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
